MabGenesis Inc.
|
| Code |
Sector |
Market |
Lead Underwriter |
Date of listing approval |
IPO Date |
| 653A |
Pharmaceuticals |
Growth |
Tokai Tokyo Securities Co., Ltd |
2026/09/28 |
2026/11/02 |
| 【Description】 |
| |
IPO Information |
| Opening Price |
Y763 |
Total Amount |
Y1,897,297,000 |
| IPO Price |
Y830 |
--Company |
Y718,318,520 |
Aggregate Value
(based on Initial Price) |
6,146
(Unit:1 million) |
--Leading Shareholder |
Y1,027,194,720 |
| Listed Shares(total) |
2,285,900 |
--Lead Manager |
Y151,783,760 |
| Trading Unit |
100 |
|
Offering Price PER
(based on previous period) |
163.39 |
Offering Price PBR
(based on previous period) |
-6.44 |
| Initial Price PER |
150.20 |
Initial Price PBR |
-5.92 |
| New Shares |
940,700 |
Existing Shares |
1,345,200（incl. O.A.） |
| Shares Outstanding |
Pre IPO |
7,114,000.00 |
PostIPO |
8,054,700.00 |
| Paid Up Capital |
PreIPO |
Y90,000,000 |
PostIPO |
Y449,159,260 |
| Use of Funds Raised |
|
Financial Data |
| Units:Y1,000 |
| Fiscal Year End |
|
Revenue |
Current Profit |
Net Profit |
Net Assets |
| 2024/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
66,161 |
-147,911 |
-148,215 |
165,888 |
| 2025/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
144,459 |
-103,525 |
-103,830 |
532,058 |
| 2026/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
337,548 |
36,436 |
36,131 |
568,190 |
Recent Quarter
2026/06 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
41,857 |
-36,894 |
-36,970 |
531,219 |
| Per Share |
Units:Y1 |
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
| 2024/03 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-24.96 |
-111.20 |
|
| 2025/03 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-16.60 |
-138.42 |
|
| 2026/03 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
5.08 |
-128.95 |
|
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
Recent Quarter
2026/06 |
Consolidated |
|
- |
- |
|
| Non-consolidated |
-5.20 |
- |
|
Comment |
| ■Over allotment (298,000) |
| Consolidated Subsidiaries |
| Name |
Address |
| Underwriters |
| Allocation |
Underwriter |
Tel |
| 95% |
Tokai Tokyo Securities Co., Ltd |
03-3566-8811 |
| 2% |
SBI SECURITIES Co.,Ltd. |
03-5562-7210 |
| 2% |
Marusan Securities Co., Ltd |
03-3272-5211 |
| 1% |
Monex, Inc |
03-4323-3800 |
| Data |
| Date of incorporation |
2019/06/03 |
| Company address |
Kanagawa 222-0033 |
| Telephone |
045-534-6033 |
| President |
|
| Homepage |
https://mabgenesis.com/ |
| Auditor |
BDO Sanyu & Co |
|
|
| Major Shareholders |
| Shareholder Name |
Ratio |
| |
15.96% |
| |
13.03% |
| |
12.43% |
| |
12.12% |
| |
8.14% |
| |
6.64% |
| |
6.51% |
| |
6.25% |
| |
4.40% |
| |
3.26% |
| Number of Employees |
15 as of 2026/08/31 |
| Birth Date of Representative |
1960/03/29 |
|
|
IPO最新情報、セミナー・イベント情報などをタイムリーにお届けします。
|
|
IPO関連ニュースをX（旧Twitter）でも掲載中。初値予想アンケートも実施中です！
|
|
今後の躍進が期待される注目銘柄のアナリストレポートをご覧いただけます。
|
|
個人投資家向けIRセミナーを開催しませんか？開催希望企業募集中！
|
|
